{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:53:26Z","timestamp":1788872006631,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["RO1 DA07908"],"award-info":[{"award-number":["RO1 DA07908"]}]},{"name":"Royal Thai Government Scholarship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.taap.2013.08.023","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T07:32:03Z","timestamp":1377847923000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impaired NFAT and NF\u03baB activation are involved in suppression of CD40 ligand expression by \u03949-tetrahydrocannabinol in human CD4+ T cells"],"prefix":"10.1016","volume":"273","author":[{"given":"Thitirat","family":"Ngaotepprutaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.F.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert E.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2013.08.023_bb0005","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.168.6.2729","article-title":"CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K\/PKB signaling pathway in primary human T cells","volume":"168","author":"Appleman","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0010","doi-asserted-by":"crossref","first-page":"e5430","DOI":"10.1371\/journal.pone.0005430","article-title":"Comparison of T cell receptor-induced proximal signaling and downstream functions in immortalized and primary T cells","volume":"4","author":"Bartelt","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2013.08.023_bb0015","doi-asserted-by":"crossref","first-page":"a002436","DOI":"10.1101\/cshperspect.a002436","article-title":"An enigmatic tail of CD28 signaling","volume":"2","author":"Boomer","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0020","doi-asserted-by":"crossref","first-page":"35450","DOI":"10.1074\/jbc.M109.006338","article-title":"Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling","volume":"284","author":"Borner","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2013.08.023_bb0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0090-9556(25)06664-4","article-title":"Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain","volume":"23","author":"Bornheim","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.08.023_bb0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.immunol.19.1.375","article-title":"The immunological synapse","volume":"19","author":"Bromley","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/biof.62","article-title":"CD40\/CD40L signaling and its implication in health and disease","volume":"35","author":"Chatzigeorgiou","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.taap.2013.08.023_bb0045","first-page":"163","article-title":"CD40\/CD40L dyad in the inflammatory and immune responses in the central nervous system","volume":"3","author":"Chen","year":"2006","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2012.03.017","article-title":"Janus kinase deregulation in leukemia and lymphoma","volume":"36","author":"Chen","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.taap.2013.08.023_bb0050","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1189\/jlb.0212082","article-title":"Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120","volume":"92","author":"Chen","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jat\/10.4.129","article-title":"Tetrahydrocannabinol stability in whole blood: plastic versus glass containers","volume":"10","author":"Christophersen","year":"1986","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.taap.2013.08.023_bb0065","doi-asserted-by":"crossref","first-page":"13175","DOI":"10.1074\/jbc.271.22.13175","article-title":"Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2","volume":"271","author":"Condie","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2013.08.023_bb0055","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2007-05-088161","article-title":"Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes","volume":"111","author":"Crist","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.taap.2013.08.023_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/IR:27:2-3:185","article-title":"CD154 transcriptional regulation in primary human CD4 T cells","volume":"27","author":"Cron","year":"2003","journal-title":"Immunol. Res."},{"key":"10.1016\/j.taap.2013.08.023_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.04.023","article-title":"Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?","volume":"166","author":"Croxford","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0080","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CDLI.11.4.635-641.2004","article-title":"Targeting CD40L: a promising therapeutic approach","volume":"11","author":"Daoussis","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1567-5769(03)00163-2","article-title":"Cannabinoids inhibit the activation of ERK MAPK in PMA\/Io-stimulated mouse splenocytes","volume":"3","author":"Faubert Kaplan","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2013.08.023_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jlb.67.2.259","article-title":"AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun","volume":"67","author":"Faubert","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0095","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbrc.2003.09.174","article-title":"Ca2+\/calcineurin signalling in cells of the immune system","volume":"311","author":"Feske","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2013.08.023_bb0100","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.4049\/jimmunol.162.7.4037","article-title":"Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation","volume":"162","author":"Ford","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI0214941","article-title":"Activation and inhibition of lymphocytes by costimulation","volume":"109","author":"Frauwirth","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2013.08.023_bb0110","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI117089","article-title":"Cyclosporin A inhibits CD40 ligand expression in T lymphocytes","volume":"93","author":"Fuleihan","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2013.08.023_bb0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.taap.2013.08.023_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2013.08.023_bb0125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: potential anticancer agents","volume":"3","author":"Guzman","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2013.08.023_bb0130","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0022-3565(24)35222-X","article-title":"Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes","volume":"291","author":"Herring","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2013.08.023_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.taap.2013.08.023_bb0140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1124\/mol.61.2.446","article-title":"Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity","volume":"61","author":"Jan","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2013.08.023_bb0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2567.2008.02991.x","article-title":"CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells","volume":"127","author":"Kaminski","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.taap.2013.08.023_bb0150","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1189\/jlb.1104652","article-title":"2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester\/ionomycin-activated mouse splenocytes independent of CB1 or CB2","volume":"77","author":"Kaplan","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb9150","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bcp.2008.06.022","article-title":"The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)","volume":"76","author":"Kaplan","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2013.08.023_bb0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1373\/clinchem.2010.152439","article-title":"Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration","volume":"57","author":"Karschner","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.taap.2013.08.023_bb0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jat\/16.4.228","article-title":"Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users","volume":"16","author":"Kelly","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.taap.2013.08.023_bb0165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0170","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.4049\/jimmunol.1003414","article-title":"CpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9- and MyD88-independent mechanism","volume":"187","author":"Landrigan","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.20020845","article-title":"The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12","volume":"196","author":"Lee","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2013.08.023_bb0180","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.iy.13.040195.003203","article-title":"Potassium and calcium channels in lymphocytes","volume":"13","author":"Lewis","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0185","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.4049\/jimmunol.166.7.4578","article-title":"Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2","volume":"166","author":"Lindgren","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.taap.2013.08.023_bb0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/toxsci\/kfp224","article-title":"Establishment of an immunoglobulin M antibody-forming cell response model for characterizing immunotoxicity in primary human B cells","volume":"112","author":"Lu","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2013.08.023_bb0200","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1189\/jlb.0608390","article-title":"Suppression of T cell costimulator ICOS by delta9-tetrahydrocannabinol","volume":"85","author":"Lu","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0205","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.169.5.2736","article-title":"IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production","volume":"169","author":"McDyer","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0210","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CDLI.10.3.376-382.2003","article-title":"NF-kappaB is involved in regulation of CD40 ligand expression on Mycobacterium bovis bacillus Calmette-Guerin-activated human T cells","volume":"10","author":"Mendez-Samperio","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0215","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11481-012-9390-z","article-title":"Differential modulation by delta9-tetrahydrocannabinol (\u03949-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells","volume":"7","author":"Ngaotepprutaram","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.taap.2013.08.023_bb0220","article-title":"Marijuana\u2014An Update from the National Institute on Drug Abuse","author":"NIDA","year":"2011"},{"key":"10.1016\/j.taap.2013.08.023_bb0225","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/eji.1830260418","article-title":"Increase of intracellular calcium is the essential signal for the expression of CD40 ligand","volume":"26","author":"Nusslein","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002040050579","article-title":"Phospholipase A2 inhibitors p-bromophenacyl bromide and arachidonyl trifluoromethyl ketone suppressed interleukin-2 (IL-2) expression in murine primary splenocytes","volume":"73","author":"Ouyang","year":"1999","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2013.08.023_bb0235","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1074\/jbc.271.11.5965","article-title":"Human native soluble CD40L is a biologically active trimer, processed inside microsomes","volume":"271","author":"Pietravalle","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2013.08.023_bb0240","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1124\/jpet.112.193003","article-title":"15-Deoxy-Delta12,14-prostaglandin J2-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor gamma ligand, modulates nuclear factor of activated T cells","volume":"342","author":"Raman","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2013.08.023_bb0245","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1124\/jpet.105.100503","article-title":"Cannabinoid-mediated elevation of intracellular calcium: a structure\u2013activity relationship","volume":"317","author":"Rao","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2013.08.023_bb0250","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1189\/jlb.0505274","article-title":"Induction of intracellular calcium elevation by Delta9-tetrahydrocannabinol in T cells involves TRPC1 channels","volume":"79","author":"Rao","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0255","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1189\/jlb.1203638","article-title":"Cannabinoid receptor-mediated regulation of intracellular calcium by delta9-tetrahydrocannabinol in resting T cells","volume":"75","author":"Rao","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0260","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4049\/jimmunol.151.5.2497","article-title":"The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells","volume":"151","author":"Roy","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0265","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1096\/fj.02-1100rev","article-title":"NF-kappaB activation pathways induced by T cell costimulation","volume":"17","author":"Schmitz","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2013.08.023_bb0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/PL00000776","article-title":"The CD40\/CD154 receptor\/ligand dyad","volume":"58","author":"Schonbeck","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.taap.2013.08.023_bb0275","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1357-2725(00)00016-9","article-title":"CD154 (CD40 ligand)","volume":"32","author":"Schonbeck","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0280","doi-asserted-by":"crossref","first-page":"29624","DOI":"10.1074\/jbc.270.50.29624","article-title":"The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation","volume":"270","author":"Schubert","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2013.08.023_bb0285","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00007890-200008150-00005","article-title":"Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction","volume":"70","author":"Smiley","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.taap.2013.08.023_bb0290","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1182\/blood-2006-12-062943","article-title":"Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1\/Th2 cytokine production","volume":"109","author":"Snyder","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.taap.2013.08.023_bb0295","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1189\/jlb.0508282","article-title":"Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol","volume":"84","author":"Springs","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0300","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2249.2001.01601.x","article-title":"NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells","volume":"125","author":"Srahna","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.taap.2013.08.023_bb0305","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.meegid.2006.12.004","article-title":"Phylogenetic analysis of the promoter region of the CD40L gene in primates and other mammals","volume":"8","author":"Steiper","year":"2008","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.taap.2013.08.023_bb0310","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1074\/jbc.271.7.3763","article-title":"The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription","volume":"271","author":"Tsytsykova","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2013.08.023_bb0315","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/np50008a001","article-title":"Constituents of Cannabis sativa L. XVII. A review of the natural constituents","volume":"43","author":"Turner","year":"1980","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.taap.2013.08.023_bb0320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40\u2013CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.taap.2013.08.023_bb0325","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.1983.179","article-title":"Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women","volume":"34","author":"Wall","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2013.08.023_bb0330","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(24)35329-7","article-title":"Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T-cells","volume":"292","author":"Yea","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2013.08.023_bb0335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0024-3205(92)90009-E","article-title":"Delta 9-tetrahydrocannabinol suppresses concanavalin A induced increase in cytoplasmic free calcium in mouse thymocytes","volume":"51","author":"Yebra","year":"1992","journal-title":"Life Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13003736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13003736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:18:50Z","timestamp":1746008330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X13003736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0041008X13003736"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2013.08.023","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired NFAT and NF\u03baB activation are involved in suppression of CD40 ligand expression by \u03949-tetrahydrocannabinol in human CD4+ T cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2013.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}